Articles by Nsisong Asanga, PhD
Phase 3 trial shows ivarmacitinib is effective and safe for moderate to severe atopic dermatitis in teens and adults.
630 Madison Ave.
Manalapan, NJ 07726
© 2025 Mashup Media, LLC, a Formedics Property. All Rights Reserved.